Rate My Professor Nicholas King

Professor Nicholas King is an Honorary Professor of Immunopathology in the School of Medical Sciences within the Faculty of Medicine and Health at the University of Sydney. He obtained his medical degree from the University of Cape Town and a PhD from the Australian National University in immunovirology between 1982 and 1986. King has been affiliated with the University of Sydney since 1988, progressing through academic positions including Professor of Immunopathology and Head of the Discipline of Pathology for 18 years. He also served as Academic Director of Sydney Cytometry and contributed to the establishment of advanced cytometry facilities. His leadership extends to the Viral Immunopathology Unit at the Charles Perkins Centre, where he oversees research into immune responses in infectious diseases. King has been recognized with the Vice-Chancellor's Award for Excellence in Teaching for his contributions to medical education.

King's research specializations include immunogenetics encompassing genetic immunology, innate immunity, humoral immunology and immunochemistry, medical microbiology, and immunology. His work has profoundly impacted the field of viral immunopathology, particularly regarding flavivirus infections and West Nile virus encephalitis. With a Google Scholar profile verifying his affiliation at the University of Sydney and listing 12,581 citations, King's publications demonstrate substantial academic influence. Key works include the highly cited "Immunopathology of flavivirus infections" by NJC King and colleagues; "Metabolic Programming Drives Protective and Inflammatory Responses in West Nile Virus Encephalitis" (2025); "Deep metabolic profiling of immune cells by spectral flow cytometry reveals heterogeneity in mitochondrial function during Mycobacterium tuberculosis infection" (2025); "NK cell profiling in West Nile virus encephalitis reveals potential therapeutic targets" (2024); "Microglia and monocytes in inflammatory CNS disease: a seven-year perspective on mechanisms sustaining pathophysiology" (2021); and "Putting PLX5622 into perspective: microglia in central nervous system disease" (2023). These studies explore metabolic regulation, immune cell heterogeneity, NK cell roles, and microglial contributions to neuroinflammation, informing potential therapeutic interventions in infectious and inflammatory diseases.